Organon Widens Business Development Lens To Maintain Women’s Health Focus
R&D Head Sandra Milligan Identifies Areas Needing Investment
Organon has not strayed from its women’s health path, but is entering into earlier deals and considering technologies beyond therapeutics, while advocating increased investment in the field.
